Company Overview and News

 
Greenply Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Greenply targets up to Rs 2,000 cr sales from engineered panel division by FY#39;20

2018-05-07 moneycontrol
Greenply Industries is eyeing up to Rs 2,000 crore turnover from its engineered panel division, which mainly consists of medium-density fibreboard products, by 2019-20 on the back of a new production facility in Andhra Pradesh that may begin commercial production by July.

 
Greenply Industries Limited - Updates

2018-04-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Greenply Industries Limited - Financial Results Updates

2018-04-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Greenply Industries to explore demerger of its MDF division into Greenpanel Industries

2018-03-22 moneycontrol
Greenply Industries’ board gave its approval for the demerger of company's MDF division into Greenpanel Industries. In an interview to CNBC-TV18, V Venkatramani, CFO of the company spoke about the latest happenings in his company and sector.

 
Company news: Greenply Industries

2018-03-21 thehindubusinessline
The board of Greenply Industries on Wednesday consented to explore an option to de-merge the MDF division into Greenpanel Industries Ltd, a wholly-owned subsidiary of the company. Details of the proposed de-merger will be communicated to the stock exchanges once the board of directors approves the same, it informed the exchanges. The board also approved expansion of the veneer line at the existing manufacturing unit of Greenply Gabon SA, Gabon, a step-down wholly-owned subsidiary, situated in West Africa.

 
Greenply Industries Limited - Outcome of Board Meeting

2018-03-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

1
Amid sell-off, brokerages bet on Reliance, Maruti, Motherson Sumi

2018-02-08 thehindubusinessline
Even though the Indian economy is forecast to witness a slight improvement in macro-economic fundamentals, namely crude oil prices, inflation and GST revenues (mostly expected in the second half), the equity market is likely to continue to be on a bumpy road in the medium term. This is mainly due to improvement in global economic outlook and rising US bond yields followed by domestic factors such as imposition of long-term capital gains tax and uncertainty over improvement in corporate performance.

 
Greenply Industries Limited - Financial Result Updates

2018-02-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Greenply Industries Limited - Outcome of Board Meeting

2018-02-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Greenply Industries Limited - Demise

2018-01-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Greenply Industries Limited - Updates

2017-12-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Plywood margin can move to 11.5-12% going ahead: Greenply Industries

2017-12-07 moneycontrol
Greenply Industries is in focus after ICICI Securities upgrade the stock to high conviction buy from hold. In an interview with CNBC-TV18, V Venkatramani, CFO of Greenply Industries discussed this and more.

Related Articles

ACIA: Acacia Communications Analysis and Research Report

7m - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...